European Lithium's A$356M Cash Cushion Shores Up Merger Hopes as Regulatory Hurdles Mount

Critical Metals' takeover of European Lithium offers a 137% premium for Greenland rare-earth assets, but ASX probe, governance issues, and Greenland permit delays cast doubt on completion.

The planned takeover of European Lithium by Critical Metals Corp carries a clear geopolitical rationale — but execution is proving far messier than the paperwork suggests. At the heart of the deal lies Tanbreez, the massive rare-earth deposit in Greenland that supplies terbium and dysprosium, both critical for electric-vehicle magnets and defence systems. Three-quarters of future output is already spoken for, and the U.S. Export-Import Bank has dangled $120 million in potential finance. China's export curbs on these materials are only suspended until November 2026, giving Western buyers a narrow window to build alternative supply chains.

European Lithium’s shareholders are being offered 0.035 Critical Metals shares for each of their own, implying a value of A$0.58 per share — a 137% premium to the last undisturbed closing price. Yet the market remains deeply unconvinced. Before the stock was suspended on the ASX it traded at A$0.415, and on European exchanges it has slipped to €0.27, down 3% on a recent day. The gap between the offer price and current levels underscores how much execution risk investors are pricing in. Still, the stock has surged 192% since January and nearly tenfold from its 12-month low, reflecting the takeover euphoria that has gradually been tempered by regulatory reality.

Management has been busy rearranging the portfolio in preparation for the merger. European Lithium recently took a stake in Helix Resources to finance a gold-lithium project in Western Australia, securing resource exposure without taking on direct operational risk. At the same time it trimmed its holding in CuFe Limited. The balance sheet is unusually strong: after selling down some of its Critical Metals shares, the company holds roughly A$356 million in cash, far above the contractual minimum. A share buyback programme is further tightening the capital base.

Three major obstacles block the path to completion. First, the ASX is investigating whether European Lithium breached its disclosure obligations after media reports about the transaction surfaced before the company formally informed the market. The exchange had originally planned to lift its trading suspension on 20 May but has delayed that pending its review. Second, governance concerns are acute: Tony Sage serves as both CEO of Critical Metals and executive chairman of European Lithium. An independent committee has been formed to protect minority shareholders and has recommended acceptance only on condition that no superior offer emerges and that a fair-value opinion is obtained.

Third, the Greenland authorities have so far refused to grant an operating permit for the Tanbreez pilot plant, which is already built. Without that approval, a critical material sampling campaign scheduled for June cannot go ahead. The permit delay adds to a growing list of regulatory snags that could push back the entire merger timeline.

In Austria, the Wolfsberg lithium project is also under pressure. The country’s Federal Administrative Court overturned an earlier decision by the Carinthian government that had exempted the project from a full environmental impact assessment. A completely new review is now required, pushing the final investment decision to the end of 2026 at the earliest. The mining licence remains valid until early 2028, and the supply contract with BMW is unaffected, but the schedule is tightening.

The first major deadline arrives in June, when European Lithium must submit a draft scheme booklet to the Australian Securities and Investments Commission. A first court hearing is set for July. The shareholder vote is pencilled in for the third quarter of 2026, with Critical Metals targeting completion in the second half of next year. Every one of the outstanding conditions — the ASX probe, Greenland permits, the independent valuation — must come in positive for the timetable to hold. Any single failure risks pushing the deal further into the future, narrowing the window before China’s export restrictions resume.